超声造影联合免疫炎症标志物预测乳腺癌腋窝淋巴结转移的价值
该研究纳入2020年1月至2023年6月接受活检或手术的401例乳腺癌患者,随机分为训练集321例和验证集80例,采用单因素、LASSO及多因素logistic回归筛选腋窝淋巴结转移危险因素并构建预测模型。联合模型AUC为0.903,优于临床模型(AUC=0.790)和超声模型(AUC=0.781),基于联合模型构建的列线图校准曲线和决策曲线分析显示预测性能良好。
要点
- 联合模型预测腋窝淋巴结转移的AUC为0.903,优于临床模型(0.790)和超声模型(0.781)。
- SII、CA125、Ki67、病理类型、病灶大小、增强模式和BI-RADS分类是腋窝淋巴结转移的显著危险因素。
- 基于联合模型构建的列线图校准曲线和决策曲线分析显示预测性能良好。
核心结论
- 结合超声特征和免疫炎症标志物的列线图可作为预测乳腺癌患者腋窝淋巴结转移的有价值工具。
研究设计与样本
- 回顾性研究,纳入2020年1月至2023年6月接受活检或手术的401例乳腺癌患者,随机分为训练集321例和验证集80例,记录临床病理数据和超声特征。
关键影像表现/征象
- 增强模式和BI-RADS分类是腋窝淋巴结转移的显著危险因素。
- 病灶大小是腋窝淋巴结转移的显著危险因素。
诊断标准与关键数值
- 联合模型预测腋窝淋巴结转移的AUC为0.903。
- 临床模型预测腋窝淋巴结转移的AUC为0.790。
- 超声模型预测腋窝淋巴结转移的AUC为0.781。
临床应用与阅片要点
- 联合模型基于SII、CA125、Ki67、病理类型、病灶大小、增强模式和BI-RADS分类构建,可用于预测乳腺癌腋窝淋巴结转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the diagnostic performance of contrast-enhanced ultrasound (CEUS) combined with immune-inflammatory markers in predicting axillary lymph node metastasis (ALNM) in breast cancer patients.
METHODS: From January 2020 to June 2023, the clinicopathological data and ultrasound features of 401 breast cancer patients who underwent biopsy or surgery were recorded. Patients were randomly divided into a training set (321 patients) and a validation set (80 patients). The risk factors for ALNM were determined using univariate, least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression analysis, and prediction models were constructed. Receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA) were used to assess their diagnostic performance.
RESULTS: Logistic regression analysis demonstrated that systemic immunoinflammatory index (SII), CA125, Ki67, pathological type, lesion size, enhancement pattern and Breast Imaging Reporting and Data System (BI-RADS) category were significant risk factors for ALNM. Three different models were constructed, and the combined model yielded an AUC of 0.903, which was superior to the clinical model (AUC=0.790) and ultrasound model (AUC=0.781). A nomogram was constructed based on the combined model, calibration curves and DCA demonstrated its satisfactory performance in predicting ALNM.
CONCLUSION: The nomogram combining ultrasound features and immune-inflammatory markers could serve as a valuable instrument for predicting ALNM in breast cancer patients.
DATA AVAILABILITY STATEMENT: The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding authors.
引用
- Song Y, Liu J, Jin C, et al. Value of Contrast-Enhanced Ultrasound Combined with Immune-Inflammatory Markers in Predicting Axillary Lymph Node Metastasis of Breast Cancer. Acad Radiol. 2024. PMID: 38918153. doi:10.1016/j.acra.2024.06.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。